Copy Number Gain of hsa-miR-569 at 3q26.2 Leads to Loss of TP53INP1 and Aggressiveness of Epithelial Cancers

Pradeep Chaluvally–Raghavan(Medical College of Wisconsin), Gordon B. Mills(The University of Texas MD Anderson Cancer Center), Elsa R. Flores(Moffitt Cancer Center), Cristian Rodriguez‐Aguayo(The University of Texas MD Anderson Cancer Center), Prahlad T. Ram(The University of Texas MD Anderson Cancer Center), Chad V. Pecot(University of North Carolina at Chapel Hill), Yiling Lu(The University of Texas MD Anderson Cancer Center), Marit Krohn(Oslo University Hospital), Gabriel Lopez‐Berestein(The University of Texas MD Anderson Cancer Center), Joe W. Gray(University of Newcastle Australia), Koei Chin(Oregon Health & Science University), Xi Zhao(Chongqing Medical University), Sunila Pradeep(PES University), Tyler J. Moss(The University of Texas MD Anderson Cancer Center), Rajesha Rupaimoole(The University of Texas MD Anderson Cancer Center), Miriam R. R. Aure(Oslo University Hospital), Mihai Gagea(The University of Texas MD Anderson Cancer Center), Philip L. Lorenzi(City Of Hope National Medical Center), Vessela N. Kristensen(Oslo University Hospital), Sylvain Peuget(Karolinska Institutet), Shuangxing Yu(The University of Texas MD Anderson Cancer Center), Avinashnarayan Venkatanarayan(Bristol-Myers Squibb (United States)), Wenbin Liu(Guangzhou University), Fan Zhang(Wenzhou Medical University), Anil K. Sood(The University of Texas MD Anderson Cancer Center), Sean E. McGuire(The University of Texas MD Anderson Cancer Center), Mark P. Hamilton(Yale University), Anne‐Lise Børresen‐Dale(Oslo University Hospital), Nelson Dusetti(Centre National de la Recherche Scientifique), Hee‐Dong Han(The University of Texas MD Anderson Cancer Center), Dong Zhang(Fudan University)
Cancer Cell
December 1, 2014
Cited by 55


Related Papers